Exhaled breath analysis for early cancer detection: Principle and progress in direct mass spectrometry techniques

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 11, 2012, Pages 1893-1902

  Badjagbo, Koffi ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cancer; Direct sampling mass spectrometry; Exhaled breath; Proton transfer reaction mass spectrometry; Selected ion flow tube mass spectrometry; Volatile biomarker

Indexed keywords

ACETONE; TUMOR MARKER; VOLATILE ORGANIC COMPOUND;

CANCER DIAGNOSIS; DIRECT SAMPLING MASS SPECTROMETRY; EXPIRED AIR; GAS CHROMATOGRAPHY; HUMAN; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON TRANSFER REACTION MASS SPECTROMETRY; REVIEW; SELECTED ION FLOW TUBE MASS SPECTROMETRY;

BREATH TESTS; EARLY DETECTION OF CANCER; EXHALATION; HUMANS; MASS SPECTROMETRY; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872942545     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0208     Document Type: Review

References (75)

1. Chappell H, De P, Dryer D, Ellison L, Logan H, MacIntyre M, et al. Canadian cancer statistics 2011. Toronto: Canadian Cancer Society 2011:4.
2. Kalogerakos K, Sofoudis C, Baltayiannis N. Early breast cancer: a review. Cancer Ther 2008;6:463 - 76.
3. Thomson G, Young KG. Cancer in Canada. Toronto: Charity Intelligence Canada 2011:7.
4. Cutler DM. Are we finally winning the war on cancer ? J Econ Perspect 2008;22:3 - 26.
5. Amann A, Spanel P, Smith D. Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 2007;7: 115 - 29.
6. Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008;3:774 - 80.
7. Prado C, Marin P, Periago JF. Application of solid-phase microextraction and gas chromatography mass spectrometry to the determination of volatile organic compounds in end-exhaled breath samples. J Chromatogr A 2003;1011:125 - 34.
8. Mueller W, Schubert J, Benzing A, Geiger K. Method for analysis of exhaled air by microwave energy desorption coupled with gas chromatography-flame ionization detection-mass spectrometry. J Chromatogr B Biomed Sci Appl 1998;716:27 - 38.
9. Chakraborty S, Banerjee D, Ray I, Sen A. Detection of biomarker in breath: a step towards non-invasive diabetes monitoring. Curr Sci 2008;94:237 - 42.
10. Karl T, Prazeller P, Mayr D, Jordan A, Rieder J, Fall R, et al. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J App Physiol 2001;91:762 - 70.
11. Smith D, Špan ěl P. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrom Rev 2005;24:661 - 700.
12. Lippi G, Cervellin G. Canine olfactory detection of cancer versus laboratory testing: myth or opportunity ? Clin Chem Lab Med 2012;50:435 - 9.
13. Melichar B, Plebani M. Cancer diagnosis: from dogs to DNA or from DNA to dogs ? Clin Chem Lab Med 2012;50:415 - 8.
14. Miekisch W, Schubert JK, Noeldge-Schomburg GE. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004;347:25 - 39.
15. Manolis A. The diagnostic potential of breath analysis. Clin Chem 1983;29:5 - 15.
16. Szulejko JE, McCulloch M, Jackson J, McKee DL, Walker JC, Solouki T. Evidence for cancer biomarkers in exhaled breath. IEEE Sens J 2010;10:185 - 210.
17. Cao W, Duan Y. Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 2006;52:800 - 11.
18. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007;1:5 - 23.
19. Chapman EA, Thomas PS, Yates DH. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications. J Breath Res 2010;4:034001.
20. Chanin TD, Merrick DT, Franklin WA, Hirsch FR. Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. Curr Opin Pulm Med 2004;10:242 - 7.
21. Corradi M, Mutti A. Exhaled breath analysis: from occupational to respiratory medicine. Acta Biomed 2005;76:20 - 9.
22. Salerno-Kennedy R, Cashman KD. Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview. Wien Klin Wochenschr 2005;117:180 - 6.
23. Smith D, Špan ěl P. The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. Analyst 2007;132:390 - 6.
24. Dweik RA. The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity. J Breath Res 2011;5:030201.
25. Risby TH, Solga SF. Current status of clinical breath analysis. Appl Phys B 2006;85:421 - 6.
26. Cao W, Duan Y. Current status of methods and techniques for breath analysis. Crit Rev Anal Chem 2007;37:3 - 13.
27. Hibbard T, Killard A. Breath ammonia analysis: clinical application and measurement. Crit Rev Anal Chem 2011;41:21 - 35.
28. Ligor T. Analytical methods for breath investigation. Crit Rev Anal Chem 2009;39:2 - 12.
29. Di Francesco F, Fuoco R, Trivella MG, Ceccarini A. Breath analysis: trends in techniques and clinical applications. Microchem J 2005;79:405 - 10.
30. Ulanowska A, Ligor T, Michel M, Buszewski B. Hyphenated and unconventional methods for searching volatile cancer biomarkers. Ecol Chem Eng S 2010;17:9 - 23.
31. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971;68:2374 - 6.
32. Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009;63:164 - 8.
33. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994;17:127 - 60.
34. Horváth L, Lázár Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur Respir J 2009;34:261 - 75.
35. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999;353:1930 - 3.
36. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, et al. Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat 2006;99:19 - 21.
37. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med 2000;28:880 - 6.
38. Phillips M, Cataneo RN, Greenberg J, Gunawardena R, Naidu A, Rahbari-Oskoui F. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J Lab Clin Med 2000;136:243 - 9.
39. Moretti M, Phillips M, Abouzeid A, Abouzeid A, Cataneo RN, Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol 2004;190:1184 - 90.
40. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res 2005;6:71.
41. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prost Leuk Ess Fat Ac 2004;70:243 - 51.
42. Knutson MD, Viteri FE. Concentrating breath samples using liquid nitrogen: a reliable method for the simultaneous determination of ethane and pentane. Anal Biochem 1996;242:129 - 35.
43. Grote C, Pawliszyn J. Solid-phase microextraction for the analysis of human breath. Anal Chem 1997;69:587 - 96.
44. Buszewski B, Ulanowska A, Kowalkowski T, Cieśliński K. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Clin Chem Lab Med 2012;50:573 - 81.
45. Badjagbo K, Moore S, SauvéS. Real-time continuous monitoring methods for airborne VOCs. Trends Analyt Chem 2007;26:931 - 40.
46. Biasioli F, Yeretzian C, Märk TD, Dewulf J, Van Langenhove H. Direct-injection mass spectrometry adds the time dimension to (B)VOC analysis. Trends Analyt Chem 2011;30:1003 - 17.
47. Lindinger W, Hansel A, Jordan A. Proton-transfer-reaction mass spectrometry (PTR - MS): on-line monitoring of volatile organic compounds at pptv levels. Chem Soc Rev 1998;27:347 - 75.
48. Lindinger W, Hansel A, Jordan A. Online monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research. Int J Mass Spectrom Ion Process 1998;173:191 - 241.
49. Hansel A, Jordan A, Holzinger R, Prazeller P, Vogel W, Lindinger W. Proton transfer reaction mass spectrometry-online trace gas analysis at the ppb level. Int J Mass Spectrom Ion Process 1995;149 - 150:609 - 19.
50. Smith D, Špan ěl P. Direct, rapid quantitative analyses of BVOCs using SIFT-MS and PTR-MS obviating sample collection. Trends Analyt Chem 2011;30:945 - 59.
51. National Institute of Standards and Technology. NIST Gas-phase ion energetics data. Available at: http://webbook.nist.gov/chemistry. Accessed 25 March, 2012.
52. de Gouw J, Warneke C, Karl T, Eerdekens G, van der Veen C, Fall R. Sensitivity and specificity of atmospheric trace gas detection by proton-transfer-reaction mass spectrometry. Int J Mass Spectrom 2003;223 - 224:365 - 82.
53. Jordan A, Haidacher S, Hanel G, Hartungen E, Herbig J, Märk L, et al. An online ultra-high sensitivity Proton-transfer-reaction mass-spectrometer combined with switchable reagent ion capability (PTR + SRI - MS). Int J Mass Spectrom 2009;286:32 - 8.
54. Jordan A, Haidacher S, Hanel G, Hartungen E, Märk L, Seehauser H, et al. A high resolution and high sensitivity proton-transferreaction time-of-flight mass spectrometer (PTR-TOF-MS). Int J Mass Spectrom 2009;286:122 - 8.
55. Graus M, Müller M, Hansel A. High resolution PTR-TOF: quantification and formula confirmation of VOC in real time. J Am Soc Mass Spectrom 2010;21:1037 - 44.
56. Herbig J, Müller M, Schallhart S, Titzmann T, Graus M, Hansel A. On-line breath analysis with PTR-TOF. J Breath Res 2009;3:027004 (10pp).
57. Smith D, Španěl P. The novel selected-ion flow tube approach to trace gas analysis of air and breath. Rapid Commun Mass Spectrom 1996;10:1183 - 98.
58. Špan ěl P, Smith D. Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom Rev 2011;30:236 - 67.
59. Špan ěl P, Smith D. Selected ion flow tube: a technique for quantitative trace gas analysis of air and breath. Med Biol Eng Comput 1996;34:409 - 19.
60. Rieder J, Lirk P, Ebenbichler C, Gruber G, Prazeller P, Lindinger W, et al. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien Klin Wochenschr 2001;113:181 - 5.
61. Amann A, Poupart G, Telser S, Ledochowski M, Schmid A, Mechtcheriakov S. Applications of breath gas analysis in medicine. Int J Mass Spectrom 2004;239:227 - 33.
62. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grabmer C, Gastl GA, et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. Int J Mass Spectrom 2007;265:49 - 59.
63. Steeghs MM, Cristescu SM, Munnik P, Zanen P, Harren FJ. An offline breath sampling and analysis method suitable for large screening studies. Physiol Meas 2007;28:503 - 14.
64. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, et al. Non-invasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009;9:348.
65. Turner C, Špan ěl P, Smith D. A longitudinal study methanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas 2006;27: 637 - 48.
66. Turner C, Špan ěl P, Smith D. A longitudinal study of ethanol and acetaldehyde in the exhaled breath of healthy volunteers using selected-ion flow-tube mass spectrometry. Rapid Commun Mass Spectrom 2006;20:61 - 8.
67. Španěl P, Dryahina K, Smith D. The concentration distributions of some metabolites in the exhaled breath of young adults. J Breath Res 2007;1:026001.
68. Španěl P, Dryahina K, Smith D. Acetone, ammonia and hydrogen cyanide in exhaled breath of several volunteers aged 4 - 83 years. J Breath Res 2007;1:011001.
69. Smith D, Španěl P. Advantages of breath testing for the early diagnosis of lung cancer. Expert Rev Mol Diagn 2010;10:255 - 7.
70. Španěl P, Smith D, Holland TA, Al Singary W, Elder JB. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 1999;13:1354 - 9.
71. Smith D, Wang TS, Sule-Suso J, Špan ěl P, El Haj A. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2003;17:845 - 50.
72. Sulé-Suso J, Pysanenko A, Španěl P, Smith D. Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS. Analyst 2009;134:2419 - 25.
73. Španěl P, Smith D. Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS. J Breath Res 2008;2:046003.
74. Ross BM. Sub-parts per billion detection of trace volatile chemicals in human breath using selected ion flow tube mass spectrometry. BMC Res Notes 2008;1:41.
75. Boshier PR, Cushnir JR, Mistry V, Knaggs A, Španěl P, Smith D, et al. On-line, real time monitoring of exhaled trace gases by SIFT-MS in the perioperative setting: a feasibility study. Analyst 2011;136:3233 - 7.